A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
Author(s) -
Lakshmi Priya,
Bini Moorthy
Publication year - 2021
Publication title -
case reports in psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.17
H-Index - 4
eISSN - 2090-682X
pISSN - 2090-6838
DOI - 10.1155/2021/5557211
Subject(s) - aripiprazole , hypersexuality , discontinuation , medicine , schizophrenia (object oriented programming) , psychiatry , clinical psychology , sexual behavior
Aripiprazole is an antipsychotic with partial agonist activity at the dopamine D2 receptor which may lead to compulsive behaviors including hypersexuality. The case presented is of a 24-year-old male with schizophrenia who developed hypersexuality symptoms after initiation of aripiprazole. Cessation of the aripiprazole led to a reduction in hypersexual behaviors. Clinicians should be aware of compulsive behaviors including hypersexuality with aripiprazole use and consider discontinuation of aripiprazole treatment in patients suffering from hypersexuality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom